Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 20 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Pharvaris N.V. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −2 vs. Q2 2021
- Shares held
- 21.6M
- +192.9K (+0.9%) vs. Q2 2021
- Total value
- $380.3M
- −$15.9M (−4.0%) vs. Q2 2021
- New holders
- 3
- 5 more added
- Sold out
- 5
- 8 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PHVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 125 | $2.23B |
| Q1 2026 | 110 | $1.67B |
| Q4 2025 | 106 | $1.64B |
| Q3 2025 | 83 | $1.44B |
| Q2 2025 | 60 | $792.7M |
| Q1 2025 | 52 | $705.5M |
| Q4 2024 | 54 | $855.8M |
| Q3 2024 | 51 | $834.2M |
| Q2 2024 | 36 | $808.6M |
| Q1 2024 | 35 | $980.5M |
| Q4 2023 | 36 | $1.14B |
| Q3 2023 | 21 | $606.6M |
| Q2 2023 | 21 | $441.6M |
| Q1 2023 | 21 | $173.9M |
| Q4 2022 | 25 | $239.6M |
| Q3 2022 | 21 | $173.6M |
| Q2 2022 | 20 | $494.0M |
| Q1 2022 | 22 | $397.1M |
| Q4 2021 | 22 | $321.1M |
| Q3 2021 | 25 | $380.3M |
| Q2 2021 | 28 | $406.3M |
| Q1 2021 | 33 | $616.5M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Pharvaris N.V.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,261,926 | $57.8M | 8.52% | 00.0% | Unchanged |
| FMR LLC | 3,312,859 | $57.1M | 0.00% | +54,642+1.7% | Added |
| Bain Capital Life Sciences Investors, LLC | 3,180,601 | $56.4M | 3.50% | 00.0% | Unchanged |
| General Atlantic LLC | 2,420,155 | $42.9M | 0.25% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 2,391,517 | $41.3M | 0.11% | 00.0% | Unchanged |
| venBio Partners LLC | 2,303,310 | $40.8M | 4.07% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 1,608,471 | $28.5M | 0.56% | +575,714+55.7% | Added |
| Cormorant Asset Management, LP | 689,731 | $12.2M | 0.50% | −55,132−7.4% | Reduced |
| VR Adviser, LLC | 552,882 | $9.80M | 1.26% | −350,000−38.8% | Reduced |
| Pictet Asset Management SA | 557,059 | $9.61M | 0.01% | +557,059 | New |
| Novo Holdings A/S | 418,943 | $7.43M | 0.38% | +307,799+276.9% | Added |
| Foresite Capital Management V, LLC | 364,142 | $6.46M | 2.01% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 244,925 | $4.22M | 0.06% | −296,638−54.8% | Reduced |
| Millennium Management LLC | 157,753 | $2.72M | 0.00% | −39,214−19.9% | Reduced |
| DAFNA Capital Management LLC | 35,074 | $622.0K | 0.17% | +35,074 | New |
| Goldman Sachs Group Inc | 30,174 | $535.0K | 0.00% | +2,382+8.6% | Added |
| Perceptive Advisors LLC | 27,000 | $479.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 18,643 | $321.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 17,547 | $311.0K | 0.00% | −2,437−12.2% | Reduced |
| Compagnie Lombard Odier SCmA | 16,670 | $287.0K | 0.01% | +1,640+10.9% | Added |
| JPMorgan Chase & Co | 15,904 | $274.0K | 0.00% | −530−3.2% | Reduced |
| Ensign Peak Advisors, Inc | 5,000 | $86.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 654 | $12.0K | 0.00% | +654 | New |
| Bank of America Corp | 500 | $9.00K | 0.00% | −50−9.1% | Reduced |
| Tower Research Capital LLC (TRC) | 211 | $4.00K | 0.00% | −350−62.4% | Reduced |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −79,837−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −71,020−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −33,382−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −13,479−100.0% | Sold out |
| Pictet Asset Management Ltd | – | – | – | – | Not filed |